Public annual accounts

SYMBIOSYS financials

A multi-period view of the public annual-account figures reported for SYMBIOSYS, with comparable measures and links to available source documents.

Company overview
Registry number

0885032453

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 29, 2026

Financial evidence

2025 versus 2024

Operating line
€38,094

+1.5%

EBITDA
€36,927

+1.4%

Total assets
€95,553

-8.6%

Equity
€66,097

-25.4%

EBITDA margin +96.9% · Equity ratio +69.2%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO
Fiscal year
Gross margin
EBITDA
Total assets
Equity
Filing
202530 Sept 2025€38,094€36,927€95,553€66,097-
202430 Sept 2024€37,546€36,414€104,496€88,640-
Gross margin line from gross margin (abbreviated schema). This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report